Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial
BELGRADE, Mont. , March 07, 2024 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions
Xtant Medical to Present at the TD Cowen 44th Annual Healthcare Conference
BELGRADE, Mont. , Feb. 26, 2024 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions
Xtant Medical to Participate in Upcoming Investor Conferences
BELGRADE, Mont. , Nov. 09, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions
Xtant Medical Announces Record Third Quarter Revenue of $25 Million
Raises 2023 Annual Revenue Guidance to $88 Million – $91 Million BELGRADE, Mont. , Nov. 09, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE
Xtant Medical to Issue Third Quarter 2023 Financial Results on November 9, 2023
BELGRADE, Mont. , Nov. 02, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions
Xtant Medical Announces Acquisition of nanOss Production Operations from RTI Surgical
Expands Xtant’s Manufacturing Capabilities and Capacity to Drive Growth BELGRADE, Mont. , Oct. 23, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT),
Xtant Medical Highlights Growing Product Portfolio at NASS 2023
BELGRADE, Mont. , Oct. 12, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions
Xtant Medical Completes Acquisition of Surgalign’s Hardware and Biologics Business
BELGRADE, Mont. , Aug. 10, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions
Xtant Medical Announces Second Quarter Revenue Growth of 32%
Raises 2023 Annual Revenue Guidance to $75 Million – $77 Million BELGRADE, Mont. , Aug. 01, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc.
Xtant Medical Wins Auction for Surgalign’s Hardware and Biologics Business
Acquisition to Enhance Xtant’s Growing Spinal Fusion Devices Portfolio BELGRADE, Mont. , July 28, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT),
Xtant Medical to Issue Second Quarter 2023 Financial Results on August 1, 2023
BELGRADE, Mont. , July 25, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions
Xtant Medical Announces Closing of $15 Million Private Placement
BELGRADE, Mont. , July 07, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions